223 related articles for article (PubMed ID: 34958403)
1. Transition Therapy: Tackling the Ecology of Tumor Phenotypic Plasticity.
Aguadé-Gorgorió G; Kauffman S; Solé R
Bull Math Biol; 2021 Dec; 84(1):24. PubMed ID: 34958403
[TBL] [Abstract][Full Text] [Related]
2. Dynamical hallmarks of cancer: Phenotypic switching in melanoma and epithelial-mesenchymal plasticity.
Jain P; Pillai M; Duddu AS; Somarelli JA; Goyal Y; Jolly MK
Semin Cancer Biol; 2023 Nov; 96():48-63. PubMed ID: 37788736
[TBL] [Abstract][Full Text] [Related]
3. Stroma-induced phenotypic plasticity offers phenotype-specific targeting to improve melanoma treatment.
Seip K; Jørgensen K; Haselager MV; Albrecht M; Haugen MH; Egeland EV; Lucarelli P; Engebraaten O; Sauter T; Mælandsmo GM; Prasmickaite L
Cancer Lett; 2018 Dec; 439():1-13. PubMed ID: 30240588
[TBL] [Abstract][Full Text] [Related]
4. Stochastic modeling of phenotypic switching and chemoresistance in cancer cell populations.
Kumar N; Cramer GM; Dahaj SAZ; Sundaram B; Celli JP; Kulkarni RV
Sci Rep; 2019 Jul; 9(1):10845. PubMed ID: 31350465
[TBL] [Abstract][Full Text] [Related]
5. The role of memory in non-genetic inheritance and its impact on cancer treatment resistance.
Cassidy T; Nichol D; Robertson-Tessi M; Craig M; Anderson ARA
PLoS Comput Biol; 2021 Aug; 17(8):e1009348. PubMed ID: 34460809
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic Switching and Filamentation in Candida haemulonii, an Emerging Opportunistic Pathogen of Humans.
Deng Y; Li S; Bing J; Liao W; Tao L
Microbiol Spectr; 2021 Dec; 9(3):e0077921. PubMed ID: 34878301
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic heterogeneity and evolution of melanoma cells associated with targeted therapy resistance.
Su Y; Bintz M; Yang Y; Robert L; Ng AHC; Liu V; Ribas A; Heath JR; Wei W
PLoS Comput Biol; 2019 Jun; 15(6):e1007034. PubMed ID: 31166947
[TBL] [Abstract][Full Text] [Related]
8. Tracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations.
Lorenzi T; Chisholm RH; Clairambault J
Biol Direct; 2016 Aug; 11(1):43. PubMed ID: 27550042
[TBL] [Abstract][Full Text] [Related]
9. Phenotype Switching and the Melanoma Microenvironment; Impact on Immunotherapy and Drug Resistance.
Hossain SM; Eccles MR
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675114
[TBL] [Abstract][Full Text] [Related]
10. Modeling differentiation-state transitions linked to therapeutic escape in triple-negative breast cancer.
Chapman MP; Risom T; Aswani AJ; Langer EM; Sears RC; Tomlin CJ
PLoS Comput Biol; 2019 Mar; 15(3):e1006840. PubMed ID: 30856168
[TBL] [Abstract][Full Text] [Related]
11. Phenotype plasticity as enabler of melanoma progression and therapy resistance.
Arozarena I; Wellbrock C
Nat Rev Cancer; 2019 Jul; 19(7):377-391. PubMed ID: 31209265
[TBL] [Abstract][Full Text] [Related]
12. ZEB1-mediated melanoma cell plasticity enhances resistance to MAPK inhibitors.
Richard G; Dalle S; Monet MA; Ligier M; Boespflug A; Pommier RM; de la Fouchardière A; Perier-Muzet M; Depaepe L; Barnault R; Tondeur G; Ansieau S; Thomas E; Bertolotto C; Ballotti R; Mourah S; Battistella M; Lebbé C; Thomas L; Puisieux A; Caramel J
EMBO Mol Med; 2016 Oct; 8(10):1143-1161. PubMed ID: 27596438
[TBL] [Abstract][Full Text] [Related]
13. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
Biswas A; De S
Am J Physiol Cell Physiol; 2021 May; 320(5):C750-C760. PubMed ID: 33657326
[TBL] [Abstract][Full Text] [Related]
14. Cancer cells exhibit clonal diversity in phenotypic plasticity.
Mathis RA; Sokol ES; Gupta PB
Open Biol; 2017 Feb; 7(2):. PubMed ID: 28202626
[TBL] [Abstract][Full Text] [Related]
15. Reversible phenotypic plasticity with continuous adaptation.
Pfab F; Gabriel W; Utz M
J Math Biol; 2016 Jan; 72(1-2):435-66. PubMed ID: 25980476
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2.
O'Connell MP; Marchbank K; Webster MR; Valiga AA; Kaur A; Vultur A; Li L; Herlyn M; Villanueva J; Liu Q; Yin X; Widura S; Nelson J; Ruiz N; Camilli TC; Indig FE; Flaherty KT; Wargo JA; Frederick DT; Cooper ZA; Nair S; Amaravadi RK; Schuchter LM; Karakousis GC; Xu W; Xu X; Weeraratna AT
Cancer Discov; 2013 Dec; 3(12):1378-93. PubMed ID: 24104062
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-222 Regulates Melanoma Plasticity.
Lionetti MC; Cola F; Chepizhko O; Fumagalli MR; Font-Clos F; Ravasio R; Minucci S; Canzano P; Camera M; Tiana G; Zapperi S; Porta CAM
J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32784455
[TBL] [Abstract][Full Text] [Related]
18. Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors.
Lorz A; Lorenzi T; Clairambault J; Escargueil A; Perthame B
Bull Math Biol; 2015 Jan; 77(1):1-22. PubMed ID: 25480478
[TBL] [Abstract][Full Text] [Related]
19. Understanding the role of phenotypic switching in cancer drug resistance.
Gunnarsson EB; De S; Leder K; Foo J
J Theor Biol; 2020 Apr; 490():110162. PubMed ID: 31953135
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic Switching of B16F10 Melanoma Cells as a Stress Adaptation Response to Fe3O4/Salicylic Acid Nanoparticle Therapy.
Mîndrilă I; Osman A; Mîndrilă B; Predoi MC; Mihaiescu DE; Buteică SA
Pharmaceuticals (Basel); 2021 Sep; 14(10):. PubMed ID: 34681232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
